Journal profile · Cell & Tissue Engineering
Stem Cells and Development
ISSN 1547-3287 · eISSN 1557-8534 · Mary Ann Liebert Inc. · UNITED STATES · Bimonthly · Founded 2004
Stem Cells and Development: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.93; hybrid open access; review about 3 months (community reports); community-reported acceptance: about 50%; 47 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Stem Cells and Development is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Mesenchymal stem cell research, Pluripotent Stem Cells Research and Tissue Engineering and Regenerative Medicine, together about 43.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Stem Cells and Development is globally recognized as the trusted source for critical, even controversial coverage of emerging hypotheses and novel findings. With a focus on stem cells of all tissue types and their potential therapeutic applications, the Journal provides clinical, basic, and translational scientists with cutting-edge research and findings. Stem Cells and Development coverage includes: Embryogenesis and adult counterparts of this process Physical processes linking stem cells, primary cell function, and structural development Hypotheses exploring the relationship between genotype and phenotype Development of vasculature, CNS, and other germ layer development and defects Pluripotentiality of embryonic and somatic stem cells The role of genetic and epigenetic factors in development
Source: LetPub
Research area (LetPub): Cell & Tissue Engineering
Main research topics OpenAlex counts of recent articles; shares are approximate
- Mesenchymal stem cell researchMedicine18.5%
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology17.1%
- Tissue Engineering and Regenerative MedicineMedicine7.8%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology6.7%
- Hematopoietic Stem Cell TransplantationMedicine6.3%
- Neurogenesis and neuroplasticity mechanismsNeuroscience4.4%
- Renal and related cancersBiochemistry, Genetics and Molecular Biology3.6%
- Cancer Cells and MetastasisMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Transplantation | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
| Minor | Transplantation | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Transplantation | Zone 3 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.93LetPub ·
- CiteScore 2026-06
- 4LetPub ·
- SJR 2026-06
- 0.53LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 100LetPub ·
- h-index
- 154OpenAlex ·
- i10-index
- 2,844OpenAlex ·
- 2-year mean citedness
- 2.41OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 11.24%LetPub ·
Volume
- Articles per year
- 45LetPub ·
Articles by year OpenAlex count · 3,862 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 6 | 6 |
| 2025 | 47 | 17 | 92 |
| 2024 | 61 | 16 | 249 |
| 2023 | 64 | 11 | 355 |
| 2022 | 73 | 20 | 664 |
| 2021 | 97 | 28 | 1,438 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2004
- ISSN
- 1547-3287
- Electronic ISSN
- 1557-8534
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Stem Cells and Development
What CAS zone is Stem Cells and Development in?
In the 2025 upgraded edition of the CAS Journal Ranking, Stem Cells and Development is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell & Tissue Engineering / Hematology / Medicine, Research & Experimental / Transplantation. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Stem Cells and Development?
The latest impact factor listed by LetPub is 1.93; CiteScore 4, h-index 154.
How long does peer review take at Stem Cells and Development?
Authors report an average review time of about 3 months; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Stem Cells and Development?
According to LetPub and DOAJ records, Stem Cells and Development is indexed in SCIE and Scopus.
Is Stem Cells and Development open access, and what is the APC?
Stem Cells and Development is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .